D & R PHARMACEUTICAL SERVICES
D & R PHARMACEUTICAL SERVICES
Industry:
Biotechnology Manufacturing Pharmaceutical
Founded:
1979-01-01
Address:
Louisville, Kentucky, United States
Country:
United States
Status:
Active
Contact:
(502)452-2616
Similar Organizations
Quest Pharmaceuticals
Quest Pharmaceuticals is a generic drug manufacturer and distributor company.
More informations about "D & R Pharmaceutical Services"
D & R Pharmaceutical Services - Crunchbase
D & R Pharmaceutical Services, LLC manufactures drugs and sundries. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»
D&R Pharmaceutical Services LLC · Omnicare of Lexington
D&R Pharmaceutical Services LLC is a Long Term Care Pharmacy (organization) practicing in Lexington, Kentucky. The National Provider Identifier (NPI) is #1912018524, which was …See details»
Kentucky: Secretary of State - Online Services
Organization Number: 0623422 : Name: D&R PHARMACEUTICAL SERVICES, LLC. Profit or Non-Profit: P - Profit : Company Type: KLC - Kentucky Limited Liability CompanySee details»
D&R Pharmaceutical Services, Llc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for D&R Pharmaceutical Services, Llc. of Cincinnati, OH. Get the latest business insights from Dun & …See details»
D & R Pharmaceutical Services LLC - Company Profile and News
Company profile page for D & R Pharmaceutical Services LLC including stock price, company news, executives, board members, and contact informationSee details»
Med Care Pharmacy #48529 in Florence - Pharmacy Location, …
Med Care Pharmacy #48529 (D&R PHARMACEUTICAL SERVICES, L.L.C.) is a Long Term Care Pharmacy in Florence, Kentucky.The NPI Number for Med Care Pharmacy #48529 is …See details»
D & R Pharmaceutical Services (R9M2DKSTK3F1) - highergov.com
Oct 1, 2023 Federal contract recipient D & R PHARMACEUTICAL SERVICES, LLC (UEI R9M2DKSTK3F1, CAGE 9NYN0) is headquartered in Florence KY. Its primary registered …See details»
D&R Pharmaceutical Services, L.L.C. · Med Care Pharmacy #48531 · …
Overview . D&R Pharmaceutical Services, L.L.C. is a Long Term Care Pharmacy (organization) practicing in Glasgow, Kentucky.The National Provider Identifier (NPI) is #1972511210, which …See details»
D & R Pharmaceutical Services - Crunchbase
D & R Pharmaceutical Services, LLC manufactures drugs and sundries.See details»
MED CARE PHARMACY #48529 - NPI 1376648287 - Pharmacy in …
Sep 14, 2006 D&R PHARMACEUTICAL SERVICES, L.L.C. Other Organization Name MED CARE PHARMACY #48529 Other Name Type Doing Business As (3) Entity Type …See details»
Pharmaceutical research and development (R&D) - Statista
Jan 10, 2024 The R&D response to the COVID-19 pandemic has made headlines worldwide, and the relentless work of pharma companies and research groups continues to support the …See details»
Canadian life science clinical research and manufacturing capabilities
An important trend in the global pharmaceutical industry over the last decade has been to externalize drug R&D programs and manufacturing, including via partnerships with academia, …See details»
A new recipe for biopharmaceutical R&D | McKinsey - McKinsey
Jul 31, 2024 Practically speaking, a “blockbuster seeking” portfolio strategy directs 80 percent or more of R&D investment to a subset of assets that have the potential to yield at least $3 billion …See details»
The convergence of AI technologies and human expertise in …
Oct 1, 2024 Strategic partnerships and collaborations: Biopharma are pursing M&A to acquire innovative pipelines, replenishing assets impacted by the patent cliff, and bolster internal R&D …See details»
The Growing Impact of CROs in the Pharma Industry
Jul 11, 2023 Beyond classical CROs in pharma, big and small, there is a growing wave of technology-first drug discovery companies which offer specialized contract research services …See details»
Pharmaceutical industry profile - Canada
R&D costs per drug averaged US$1.4 billion over 12–13 years (Tufts Center for the Study of Drug Development). Full costing (including amortization of research failures and opportunity cost of …See details»
2025 life sciences outlook | Deloitte Insights
A recent Deloitte Center for Health Solutions report on measuring the return from innovation illustrates how some pharmaceutical organizations are integrating gen AI and other advanced …See details»
The end of the R&D organization as we know it – Pharma’s ... - STAT
Aug 20, 2021 By Marc P. Philipp and Katie Miinch. Shifting pharma spend from billions to millions requires revisiting R&D organizational design. F or decades, biopharma executives …See details»
Recommended Stories
10 hours ago The Contract Manufacturing and Development Organizations (CMO/CDMO) Market, growing at a CAGR of 5.86%, Fueled by Biologics, Personalized Medicine, and …See details»
Transforming biopharma R&D at scale | McKinsey - McKinsey
May 6, 2022 As stakeholder needs evolve and the pharma landscape changes, other R&D organizations should consider following their example—or risk getting left behind. Steven …See details»